First Time Loading...

Beijing Hotgen Biotech Co Ltd
SSE:688068

Watchlist Manager
Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd
SSE:688068
Watchlist
Price: 28.44 CNY 1.68% Market Closed
Updated: Apr 28, 2024
Beijing Hotgen Biotech Co Ltd
/
Cash Flow Statement
/
Cash from Operating Activities

Beijing Hotgen Biotech Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Hotgen Biotech Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
603259
300759
2269
300347
W
2268

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Hotgen Biotech Co Ltd
SSE:688068
Cash from Operating Activities
¥978.8m
CAGR 3-Years
270%
CAGR 5-Years
112%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash from Operating Activities
¥13.4B
CAGR 3-Years
50%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash from Operating Activities
¥2.8B
CAGR 3-Years
19%
CAGR 5-Years
28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash from Operating Activities
¥6.8B
CAGR 3-Years
54%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash from Operating Activities
¥1.2B
CAGR 3-Years
5%
CAGR 5-Years
17%
CAGR 10-Years
31%
W
WuXi XDC Cayman Inc
HKEX:2268
Cash from Operating Activities
¥251.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Beijing Hotgen Biotech Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
978.8m CNY

Based on the financial report for Dec 31, 2022, Beijing Hotgen Biotech Co Ltd's Cash from Operating Activities amounts to 978.8m CNY.

What is Beijing Hotgen Biotech Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
112%

Over the last year, the Cash from Operating Activities growth was -63%. The average annual Cash from Operating Activities growth rates for Beijing Hotgen Biotech Co Ltd have been 270% over the past three years , 112% over the past five years .

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.